Tomas Karsky
About Tomas Karsky
Tomas Karsky is the Sr. Manager of Marketing for the Business Unit Innovative Medicine at Bristol Myers Squibb in Prague, Czech Republic, with extensive experience in product marketing across various pharmaceutical companies.
Title
Tomas Karsky holds the title of Sr. Manager, Marketing, Business Unit Innovative Medicine at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
Currently, Tomas Karsky is positioned as Sr. Manager, Marketing, Business Unit Innovative Medicine at Bristol Myers Squibb, based in Prague, the Capital, Czech Republic. He has been in this role since January 2023, bringing a strategic approach to pharmaceutical marketing and working closely with cross-functional teams to ensure the successful launch and ongoing promotion of new medicines.
Previous Experience at Bristol Myers Squibb
Tomas Karsky worked as Sr. Marketing Manager at Bristol Myers Squibb from 2018 to 2022, for a duration of 4 years in Hlavní město Praha, Česko. During this time, he developed and executed marketing strategies and scientific educational programs in the Innovative Medicine Field.
Roles at Celgene and Biogen
Before his tenure at Bristol Myers Squibb, Tomas Karsky served as Sr. Product Manager at Celgene from 2016 to 2018 in Prague, and as Sr. Product Manager at Biogen from 2014 to 2015. In these roles, he gained substantial experience in product marketing for critical therapeutic areas such as multiple sclerosis.
Earlier Career at AstraZeneca, Orion Pharma, and JS PARTNER
Tomas Karsky's prior experience includes roles at AstraZeneca as Product Manager from 2010 to 2013 and Orion Pharma as Product & Sales Manager from 2009 to 2010 in Prague. Additionally, he worked as a Contractor at JS PARTNER from 2008 to 2009. These roles allowed him to hone his marketing skills in the fields of intensive care and hematology.
Education Background
Tomas Karsky graduated from Slovak Agriculture University, achieving an Engineering degree in Agriculture (Ing.) from 1997 to 2002. He further enhanced his language skills by studying English at the State Registered Language School, Zlin, from 2002 to 2003. His educational background provided a solid foundation for his career in the pharmaceutical industry.